These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 26543681)

  • 21. The molecular basis of keloid and hypertrophic scar formation.
    Tuan TL; Nichter LS
    Mol Med Today; 1998 Jan; 4(1):19-24. PubMed ID: 9494966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct and Indirect Roles of Macrophages in Hypertrophic Scar Formation.
    Feng Y; Sun ZL; Liu SY; Wu JJ; Zhao BH; Lv GZ; Du Y; Yu S; Yang ML; Yuan FL; Zhou XJ
    Front Physiol; 2019; 10():1101. PubMed ID: 31555142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regenerative healing, scar-free healing and scar formation across the species: current concepts and future perspectives.
    Ud-Din S; Volk SW; Bayat A
    Exp Dermatol; 2014 Sep; 23(9):615-9. PubMed ID: 24863070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The IL-4/IL-13 axis in skin fibrosis and scarring: mechanistic concepts and therapeutic targets.
    Nguyen JK; Austin E; Huang A; Mamalis A; Jagdeo J
    Arch Dermatol Res; 2020 Mar; 312(2):81-92. PubMed ID: 31493000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanotransduction in Wound Healing and Fibrosis.
    Kuehlmann B; Bonham CA; Zucal I; Prantl L; Gurtner GC
    J Clin Med; 2020 May; 9(5):. PubMed ID: 32403382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular Endothelial Growth Factor and Cutaneous Scarring.
    Wilgus TA
    Adv Wound Care (New Rochelle); 2019 Dec; 8(12):671-678. PubMed ID: 31750015
    [No Abstract]   [Full Text] [Related]  

  • 27. Abnormal wound healing: keloids.
    Robles DT; Berg D
    Clin Dermatol; 2007; 25(1):26-32. PubMed ID: 17276198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The link between hypertension and pathological scarring: does hypertension cause or promote keloid and hypertrophic scar pathogenesis?
    Huang C; Ogawa R
    Wound Repair Regen; 2014; 22(4):462-6. PubMed ID: 24899409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical high-molecular-weight hyaluronan and a roofing barrier sheet equally inhibit postlaminectomy fibrosis.
    Akeson WH; Massie JB; Huang B; Giurea A; Sah R; Garfin SR; Kim CW
    Spine J; 2005; 5(2):180-90. PubMed ID: 15749618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical Evaluation of Leptin Expression in Wound Healing: A Clue to Exuberant Scar Formation.
    Seleit I; Bakry OA; Samaka RM; Tawfik AS
    Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):296-306. PubMed ID: 26258753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypertrophic scars and keloids.
    Haverstock BD
    Clin Podiatr Med Surg; 2001 Jan; 18(1):147-59. PubMed ID: 11344975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrins as Modulators of Transforming Growth Factor Beta Signaling in Dermal Fibroblasts During Skin Regeneration After Injury.
    Boo S; Dagnino L
    Adv Wound Care (New Rochelle); 2013 Jun; 2(5):238-246. PubMed ID: 24527345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Making sense of hypertrophic scar: a role for nerves.
    Scott JR; Muangman P; Gibran NS
    Wound Repair Regen; 2007; 15 Suppl 1():S27-31. PubMed ID: 17727464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The molecular basis of hypertrophic scars.
    Zhu Z; Ding J; Tredget EE
    Burns Trauma; 2016; 4():2. PubMed ID: 27574672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous Scarring: Basic Science, Current Treatments, and Future Directions.
    Marshall CD; Hu MS; Leavitt T; Barnes LA; Lorenz HP; Longaker MT
    Adv Wound Care (New Rochelle); 2018 Feb; 7(2):29-45. PubMed ID: 29392092
    [No Abstract]   [Full Text] [Related]  

  • 36. Upregulation of the Wnt/beta-catenin pathway induced by transforming growth factor-beta in hypertrophic scars and keloids.
    Sato M
    Acta Derm Venereol; 2006; 86(4):300-7. PubMed ID: 16874413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular dissection of abnormal wound healing processes resulting in keloid disease.
    Shih B; Garside E; McGrouther DA; Bayat A
    Wound Repair Regen; 2010; 18(2):139-53. PubMed ID: 20002895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Control of wound contraction. Basic and clinical features.
    Nedelec B; Ghahary A; Scott PG; Tredget EE
    Hand Clin; 2000 May; 16(2):289-302. PubMed ID: 10791174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-dose enalapril in the treatment of surgical cutaneous hypertrophic scar and keloid--two case reports and literature review.
    Iannello S; Milazzo P; Bordonaro F; Belfiore F
    MedGenMed; 2006 Dec; 8(4):60. PubMed ID: 17415337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibrillin-1 and elastin are differentially expressed in hypertrophic scars and keloids.
    Amadeu TP; Braune AS; Porto LC; Desmoulière A; Costa AM
    Wound Repair Regen; 2004; 12(2):169-74. PubMed ID: 15086768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.